Wuhan Healthgen Biotechnology Corp.

Company Description

Healthgen Biotechnology Co., Ltd. is a private Company, which was founded in 2006. Wuhan Healthgen Biotechnology Corp. focusing on developing, manufacturing and marketing a series of environmental friendly and safe products by using the State-of-the-Art platform of OryzExpress, which includes the highly expressing proteins or small peptides in cereal crop endosperm.

Utilizing the OryzExpress platform, Healthgen Biotechnology develops and markets innovative animal-free products for industrial and pharmaceutical use. Its economically advantaged expression capability made it become a breakthrough and innovative protein expression platform.

Gained a number of patented technologies, Healthgen Biotechnology had achievements in developing and commercializing products, such as: OsrHSA (recombinant human serum albumin), OsrAAT(recombinant anti-trypsin), OsraFGF(recombinant acid fibroblast growth factor), OsrbFGF(recombinant basic fibroblast growth factor) and OsrIGF-1(recombinant insulin-like growth factor). These products are widely used for cell culture media, cosmetic additives, industrial reagents, bio-pharmaceuticals and life science research.

Healthgen Biotechnology's Quality Management System has been certified by SGS against the ISO 9001: 2008 requirements, which ensure standardized process as well as qualified products.